• SENSEX 81,373.75
    -77.26 (--0.09%)
  • BANKNIFTY 55,903.40
    153.70 (+0.28%)
  • Niva Bupa Health
    82.00 61.01(%)
  • Reliance Power
    62.80 62.80(%)
  • Max Healthcare
    1,159.45 1,227.50(%)
  • Mazagon Dock
    3,376.20 1,200.00(%)
  • Garden Reach Sh.
    2,875.00 1,148.10(%)
  • Suzlon Energy
    70.75 45.13(%)
  • Yes Bank
    23.40 27.41(%)
  • St Bk of India
    822.50 912.10(%)
  • Indian Energy Ex
    198.35 134.30(%)
  • Reliance Infra.
    359.50 359.50(%)
  • Inox Wind
    184.30 124.35(%)
  • Reliance Industr
    1,395.90 1,115.55(%)
  • Eternal Ltd
    243.00 304.50(%)
  • M & M
    3,037.05 3,276.30(%)
  • Larsen & Toubro
    3,697.00 3,963.00(%)
  • Aegis Vopak Term
    241.95 241.95(%)
  • Astrazeneca Phar
    9,477.00 9,477.00(%)
  • TCS
    3,418.30 3,060.25(%)
  • Kotak Mah. Bank
    2,051.30 1,602.20(%)
  • Ola Electric
    54.40 157.53(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Norris Medicines Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3347.0
  • ISIN : INE744C01029
19.48 -1 (-4.98%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    19.48

  • Today’s High

    21.45

  • Open

    21.45

  • Perv Close

    20.50

  • 52W Low

    11.30

  • 52W High

    27.74

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    19.48

  • Div & Yield %

    0.00

  • Book Value(₹)

    -14.79

  • Debt-Equity Ratio

    -4.98

  • AGM Date

    02-Jun-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    19.48

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.00

  • BV (₹)

    -14.80

  • Sales( ₹ in Cr.)

    5.82

  • NP (in Cr.)

    -1.24

  • NP Var(%)

    -6.0

  • Div%

    0.0

  • CPS (₹)

    -0.70

  • EPS (₹)

    -1.20

  • Traded Value (₹ in Lakhs)

    20.50

  • 52 Week High

    27.74

  • 52 Week Low

    11.30

  • Price BSE

    21.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    20.50

  • P/C Ratio

    -30.00

  • P/E Ratio

    -17.00

  • Price Vs.BV

    -1.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 5.64 8.36 9.44 12.25 7.90 16.34
Excise Duty 0.00 0.00 0.00 0.00 0.06 0.08
Net Sales 5.64 8.36 9.44 12.25 7.84 16.26
Other Income 0.03 0.01 0.03 0.05 0.09 0.04
Stock Adjustments 0.50 -0.13 -2.04 0.79 0.64 -0.14
Total Income 6.17 8.24 7.43 13.09 8.57 16.16
EXPENDITURE :            
Raw Materials 3.16 3.23 3.57 9.53 5.16 10.04
Power and Fuel Cost 0.76 0.90 0.81 0.97 1.22 1.54
Employee Cost 1.82 2.30 2.33 3.10 3.23 3.81
Other Manufacturing Expenses 0.19 0.38 0.28 0.37 0.48 0.63
Selling and Administration Expenses 0.34 0.43 0.39 0.68 0.55 0.72
Miscellaneous Expenses 0.05 0.06 0.09 0.13 0.00 0.01
Employee Benefit Expenses 1.82 2.30 2.33 3.10 3.23 3.81
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6.32 7.30 7.47 14.78 10.63 16.74
Operating Profit -0.16 0.94 -0.05 -1.70 -2.07 -0.57
Interest 0.37 1.50 1.48 1.63 0.88 0.73
Gross Profit -0.53 -0.56 -1.53 -3.33 -2.95 -1.30
Depreciation 0.57 0.63 0.66 0.67 0.73 0.71
Profit Before Tax -1.10 -1.19 -2.19 -4.00 -3.68 -2.01
Current Tax 0.00 0.00 0.00 0.00 -0.84 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.09 0.56 1.08 0.97 0.00 -0.33
Reported Net Profit -1.19 -1.75 -3.26 -4.96 -2.84 -1.68
Extraordinary Items -0.02 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -1.17 -1.75 -3.26 -4.96 -2.84 -1.68
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -24.20 -22.45 -19.19 -14.23 -11.39 -9.71
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -25.39 -24.20 -22.45 -19.19 -14.23 -11.39
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.20 -1.76 -3.29 -5.00 -2.86 0.00
Earnings Per Share(Adj)-Unit Curr -1.20 -1.76 - -5.00 -2.86 0.00
Book Value -13.73 -12.54 -10.77 -7.49 -2.49 0.38
Book Value(Adj)-Unit Curr -13.73 -12.54 - -7.49 -2.49 0.38

Shareholding Pattern

  • Promoter Group

    34.00%

  • Public Share Holding

    66.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,000,000 10.00 1,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,400,131 24.00 2,398,631 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,400,131 34.00 3,398,631 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,420 0.06 6,420 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 510 0.01 0 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 6,930 0.07 6,420 6
2] Non Institution
Bodies Corporate 4,394,167 43.94 4,363,417 61
Clearing Members 38,946 0.39 38,946 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 39,786 0.40 39,786 54
Foreign Non Institution Other 27,150 0.27 27,150 2
Hindu Undivided Families 17,191 0.17 17,191 58
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 27,480 0.27 27,480 1
Individuals holding nominal share capital up to Rs. 1 lakh 2,048,731 20.49 772,378 25,623
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 90 0.00 90 1
Others 0 0.00 0 0
Sub Total 6,593,639 65.93 5,286,536 25,804
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,000,700 100.00 8,691,587 25,815

Company Background

Norris Medicines LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Norris Medicines Ltd
  • BSE Code : 3347.0
  • ISIN : INE744C01029

  • Incorporation Year

    1990

  • Registered Office

    Plot No 801/P & 802
    GIDC Industrial Estate, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-2646-223462/227530

  • FAX

    91-2646-250126

  • Chairman

  • Managing Director

    Vimal D Shah

  • Company Secretary

    Priyanka Lohiya

  • Auditor

    Bahedia & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Norris Medicines Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Norris Medicines 19.48 5.66 5.64 -15.71 0.00
Abbott India 30,663.80 6,097.18 5,848.91 46.07 44.71
Astrazeneca Phar 9,315.65 1,330.33 1,295.53 201.20 33.26
P & G Health Ltd 5,758.05 1,166.89 1,151.26 38.05 39.76
Glaxosmi. Pharma 3,271.55 3,530.73 3,407.25 60.31 44.44
Cipla 1,469.75 17,645.00 16,574.34 23.02 20.10
Amrutanjan Healt 719.00 437.58 421.23 40.90 20.84
Fermenta Biotec. 318.15 315.24 307.09 13.85 4.10
Guj. Themis Bio. 309.40 174.19 169.82 69.06 44.82
Bliss GVS Pharma 133.80 638.96 605.46 20.43 11.19
Ambalal Sarabhai 37.10 11.70 3.81 34.35 1.92